Payment overview · 2025
General Payments
$82.21
3 reported records · 2 companies
Healthcare provider profile · identity verified
Syed Faiz Rahman, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · HENDERSON, NV · NPI 1427169986
Verified facts
What the public records show
CMS Open Payments records show Syed Faiz Rahman, M.D. received $82.21 in general payments during 2025 across 3 reported records.
Exact Sciences Corporation accounted for 65.9% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 4 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $54.14 | 65.9% | 2 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $28.07 | 34.1% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $82.21 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $34.46 | 1 | 2025 |
Source payment records
|
|||||
| OTEZLA Normalized: otezla |
Drug | Amgen Inc. | $28.07 | 1 | 2025 |
Source payment records
|
|||||
| REPATHA Normalized: repatha |
Biological | Amgen Inc. | $28.07 | 1 | 2025 |
Source payment records
|
|||||
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $19.68 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 673 | 166 |
| Gabapentin | Gabapentin | 424 | 80 |
| Eliquis | Apixaban | 421 | 48 |
| Montelukast Sodium | Montelukast Sodium | 365 | 107 |
| Pantoprazole Sodium | Pantoprazole Sodium | 345 | 89 |
| Amlodipine Besylate | Amlodipine Besylate | 328 | 78 |
| Furosemide | Furosemide | 304 | 65 |
| Levothyroxine Sodium | Levothyroxine Sodium | 303 | 77 |
| Lisinopril | Lisinopril | 287 | 70 |
| Metformin Hcl | Metformin Hcl | 241 | 56 |
| Omeprazole | Omeprazole | 228 | 70 |
| Metoprolol Tartrate | Metoprolol Tartrate | 225 | 63 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 204 | 70 |
| Tamsulosin Hcl | Tamsulosin Hcl | 197 | 46 |
| Carvedilol | Carvedilol | 178 | 38 |
| Hydralazine Hcl | Hydralazine Hcl | 173 | 38 |
| Meloxicam | Meloxicam | 163 | 62 |
| Losartan Potassium | Losartan Potassium | 157 | 48 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 44 |
| Potassium Chloride | Potassium Chloride | 150 | 36 |
| Alprazolam | Alprazolam | 129 | 27 |
| Famotidine | Famotidine | 125 | 48 |
| Trazodone Hcl | Trazodone Hcl | 119 | 34 |
| Donepezil Hcl | Donepezil Hcl | 108 | 26 |
| Spironolactone | Spironolactone | 102 | 25 |
| Memantine Hcl | Memantine Hcl | 99 | 12 |
| Levetiracetam | Levetiracetam | 90 | 15 |
| Divalproex Sodium | Divalproex Sodium | 84 | 11 |
| Duloxetine Hcl | Duloxetine Hcl | 83 | 15 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 83 | 12 |
| Sertraline Hcl | Sertraline Hcl | 83 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 82 | 28 |
| Quetiapine Fumarate | Quetiapine Fumarate | 78 | 14 |
| Temazepam | Temazepam | 78 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 76 | 13 |
| Cephalexin | Cephalexin | 76 | 58 |
| Sucralfate | Sucralfate | 76 | 23 |
| Zolpidem Tartrate | Zolpidem Tartrate | 76 | 16 |
| Metoprolol Succinate | Metoprolol Succinate | 75 | 26 |
| Prednisone | Prednisone | 75 | 29 |
| Novolog Flexpen | Insulin Aspart | 72 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 71 | 30 |
| Simvastatin | Simvastatin | 67 | 27 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 67 | 23 |
| Ropinirole Hcl | Ropinirole Hcl | 66 | 11 |
| Allopurinol | Allopurinol | 62 | 20 |
| Lactulose | Lactulose | 59 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 58 | 20 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 57 | 13 |
| Cholestyramine | Cholestyramine (With Sugar) | 53 | suppressed |
| Baclofen | Baclofen | 52 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 51 | 12 |
| Metoclopramide Hcl | Metoclopramide Hcl | 49 | 16 |
| Mirtazapine | Mirtazapine | 49 | 15 |
| Clonidine Hcl | Clonidine Hcl | 48 | 19 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 48 | 29 |
| Alendronate Sodium | Alendronate Sodium | 47 | 14 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 46 | 16 |
| Enoxaparin Sodium | Enoxaparin Sodium | 46 | suppressed |
| Celecoxib | Celecoxib | 45 | 12 |
| Finasteride | Finasteride | 44 | 11 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 43 | 15 |
| Azithromycin | Azithromycin | 42 | 33 |
| Heparin Sodium | Heparin Sodium,porcine | 42 | suppressed |
| Topiramate | Topiramate | 42 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 41 | 15 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 34 |
| Buspirone Hcl | Buspirone Hcl | 39 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 39 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 39 | suppressed |
| Atenolol | Atenolol | 38 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 38 | 12 |
| Fenofibrate | Fenofibrate Nanocrystallized | 38 | suppressed |
| Gemfibrozil | Gemfibrozil | 38 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 37 | suppressed |
| Clonazepam | Clonazepam | 36 | 14 |
| Farxiga | Dapagliflozin Propanediol | 34 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 34 | 12 |
| Risperidone | Risperidone | 33 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 33 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 32 | 11 |
| Digoxin | Digoxin | 31 | suppressed |
| Methylprednisolone | Methylprednisolone | 31 | 28 |
| Meclizine Hcl | Meclizine Hcl | 29 | 16 |
| Torsemide | Torsemide | 29 | suppressed |
| Fenofibrate | Fenofibrate | 28 | suppressed |
| Glimepiride | Glimepiride | 28 | suppressed |
| Budesonide | Budesonide | 27 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 27 | 11 |
| Bupropion Xl | Bupropion Hcl | 26 | suppressed |
| Glipizide | Glipizide | 26 | suppressed |
| Ezetimibe | Ezetimibe | 25 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 25 | suppressed |
| Ibuprofen | Ibuprofen | 25 | 16 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 25 | 14 |
| Scopolamine | Scopolamine | 25 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 25 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 25 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 25 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 24 | 12 |
| Humulin N Kwikpen | Insulin Nph Human Isophane | 24 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 23 | 20 |
| Formoterol Fumarate | Formoterol Fumarate | 23 | suppressed |
| Synthroid | Levothyroxine Sodium | 23 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Dropsafe Pen Needle | Pen Needle, Diabetic, Safety | 22 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 22 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 22 | suppressed |
| Arformoterol Tartrate | Arformoterol Tartrate | 21 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 21 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 21 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 20 | 20 |
| Belsomra | Suvorexant | 20 | suppressed |
| Dexamethasone | Dexamethasone | 20 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 20 | suppressed |
| Valproic Acid | Valproic Acid | 20 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | 12 |
| Ozempic | Semaglutide | 19 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 18 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Bumetanide | Bumetanide | 17 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Mupirocin | Mupirocin | 17 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 17 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 16 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 16 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 15 | suppressed |
| Januvia | Sitagliptin Phosphate | 15 | suppressed |
| Pregabalin | Pregabalin | 15 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 15 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 15 | suppressed |
| Tamoxifen Citrate | Tamoxifen Citrate | 15 | suppressed |
| Ciclopirox | Ciclopirox | 14 | suppressed |
| Dextrose 5%-0.9% Nacl | Dextrose 5 % And 0.9 % Nacl | 14 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 14 | suppressed |
| Levemir Flexpen | Insulin Detemir | 14 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 14 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 14 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 13 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 13 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Metronidazole | Metronidazole | 13 | 13 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 13 | suppressed |
| Amoxicillin | Amoxicillin | 12 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 12 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 12 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 12 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Dabigatran Etexilate | Dabigatran Etexilate Mesylate | 11 | suppressed |
| Fluconazole | Fluconazole | 11 | suppressed |
| Galantamine Er | Galantamine Hbr | 11 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 11 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 11 | suppressed |
| Levofloxacin | Levofloxacin | 11 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 11 | suppressed |
| Meropenem-0.9% Nacl | Meropenem-0.9% Sodium Chloride | 11 | suppressed |
| Mounjaro | Tirzepatide | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Nystop | Nystatin | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Permethrin | Permethrin | 11 | suppressed |
| Roflumilast | Roflumilast | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $82.21 · 3 records | Exact Sciences Corporation | Cologuard Collection Kit, OTEZLA, REPATHA, The Cologuard Plus Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error